Literature DB >> 11122245

Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

I Desombere1, Y Gijbels, A Verwulgen, G Leroux-Roels.   

Abstract

To study the regulation of the human cellular immune response to HBsAg we produced a series of HBsAg-specific T cell lines from good and poor responders to the hepatitis B vaccine. All T cell lines expressed CD4 on their membrane and could therefore be considered of the helper/inducer phenotype. The different HBsAg-specific T cell lines were restricted by HLA-DRB5*0101, DRB1*1201, -DRB1*0701, -DRB1*0301, -DPB1*0201, -DPB1*0402, and -DPB1*0901. In good responders to the hepatitis B vaccine different HLA molecules could act as restricting element. In poor responders the diversity of HLA class II restriction determinants was more limited. This leads us to conclude that the immune response to HBsAg is multispecific and polyclonal in good responders and paucispecific and oligoclonal in poor responders to the hepatitis B vaccine. By using a panel of synthetic peptides representing selected sequences of the HBsAg, the fine specificities of each of these T cell lines could be determined. Strikingly, the majority of the identified T cell epitopes was located in and around the first hydrophobic transmembranous region of the HBsAg. This was observed in T cell lines from good and poor vaccine responders, without distinction. The remarkable T cell immunogenicity of this region may reside in its richness in binding motifs for a variety of HLA class II determinants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122245      PMCID: PMC1905794          DOI: 10.1046/j.1365-2249.2000.01383.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

1.  The influence of host factors and immunogenetics on lymphocyte responses to Hepagene vaccination.

Authors:  A B McDermott; J A Madrigal; C A Sabin; J N Zuckerman; S B Cohen
Journal:  Vaccine       Date:  1999-03-17       Impact factor: 3.641

2.  Identification of an epitope for T-cells correlated with antibody response to hepatitis B surface antigen in vaccinated humans.

Authors:  W P Min; N Kamikawaji; M Mineta; T Tana; S Kashiwagi; T Sasazuki
Journal:  Hum Immunol       Date:  1996-04       Impact factor: 2.850

3.  Identification of a putative motif for binding of peptides to HLA-DQ2.

Authors:  B H Johansen; F Vartdal; J A Eriksen; E Thorsby; L M Sollid
Journal:  Int Immunol       Date:  1996-02       Impact factor: 4.823

4.  Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.

Authors:  E Celis; D Ou; L Otvos
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

5.  The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.

Authors:  F Vartdal; B H Johansen; T Friede; C J Thorpe; S Stevanović; J E Eriksen; K Sletten; E Thorsby; H G Rammensee; L M Sollid
Journal:  Eur J Immunol       Date:  1996-11       Impact factor: 5.532

6.  Normal HBsAg presentation and T-cell defect in the immune response of nonresponders.

Authors:  M Salazar; H Deulofeut; C Granja; R Deulofeut; D E Yunis; D Marcus-Bagley; Z Awdeh; C A Alper; E J Yunis
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 7.  Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine.

Authors:  F E André; A Safary
Journal:  Postgrad Med J       Date:  1987       Impact factor: 2.401

Review 8.  Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production.

Authors:  J N Zuckerman
Journal:  J Med Virol       Date:  1996-12       Impact factor: 2.327

Review 9.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

10.  Humoral immune response after hepatitis-B-vaccination: kinetics of anti-HBs antibodies and demonstration of HLA antigens.

Authors:  V Usonis; P Kühnl; H D Brede; H W Doerr
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-09
View more
  16 in total

1.  HLA class II associated with outcomes of hepatitis B and C infections.

Authors:  Akihiro Tamori; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.

Authors:  I Desombere; T Cao; Y Gijbels; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 3.  Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.

Authors:  Giovanna Vitaliti; Andrea Domenico Praticò; Carla Cimino; Giovanna Di Dio; Elena Lionetti; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

4.  Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies.

Authors:  A Kruger; P Adams; J Hammer; W O Böcher; P M Schneider; C Rittner; T Hoehler
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

5.  Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.

Authors:  Julia Schwaiger; Judith H Aberle; Karin Stiasny; Bernhard Knapp; Wolfgang Schreiner; Ingrid Fae; Gottfried Fischer; Ondrej Scheinost; Vaclav Chmelik; Franz X Heinz
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

6.  DRB1*12:01 presents a unique subset of epitopes by preferring aromatics in pocket 9.

Authors:  I-Ting Chow; Eddie A James; Venus Tan; Antonis K Moustakas; George K Papadopoulos; William W Kwok
Journal:  Mol Immunol       Date:  2011-12-23       Impact factor: 4.407

7.  Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.

Authors:  Isabelle Desombere; Annick Willems; Yvonne Gijbels; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.

Authors:  Ye-Gui Jiang; Yu-Ming Wang; Tong-Hua Liu; Jun Liu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

9.  Anti-HBs cellular immune response in kidney recipients before and 4 months after transplantation.

Authors:  Patricia Aguilar; Edith Renoult; Loraine Jarrosson; Marie Nathalie Kolopp-Sarda; Christine Prin Mathieu; Gilbert C Faure; Michele Kessler; Marie C Bene; Chantal Kohler; Anne Kennel De March
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

10.  A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers.

Authors:  Sylvia M Kiertscher; Pallavi R Gangalum; Grace Ibrahim; Donald P Tashkin; Michael D Roth
Journal:  J Neuroimmune Pharmacol       Date:  2018-01-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.